Omega-3 fatty acids and cognitive decline: modulation by ApoEε4 allele and depression

[1]  B. Penninx,et al.  Salivary cortisol, APOE-ε4 allele and cognitive decline in a prospective study of older persons , 2011, Neurobiology of Aging.

[2]  H. Schipper.  Apolipoprotein E: Implications for AD neurobiology, epidemiology and risk assessment , 2011, Neurobiology of Aging.

[3]  H. Vankova.  Mini Mental State , 2010 .

[4]  P. Barberger-Gateau,et al.  Fish, docosahexaenoic acid and Alzheimer's disease. , 2009, Progress in lipid research.

[5]  R. McNamara.  Evaluation of docosahexaenoic acid deficiency as a preventable risk factor for recurrent affective disorders: current status, future directions, and dietary recommendations. , 2009, Prostaglandins, leukotrienes, and essential fatty acids.

[6]  J. Lindsay,et al.  Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging. , 2009, The American journal of clinical nutrition.

[7]  H. Amièva,et al.  Prodromal Alzheimer's disease: Successive emergence of the clinical symptoms , 2008, Annals of neurology.

[8]  P. Barberger‐Gateau,et al.  Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk. , 2008, The American journal of clinical nutrition.

[9]  A. Beekman,et al.  Effect of fish oil on cognitive performance in older subjects , 2008, Neurology.

[10]  F. Gomez-Pinilla,et al.  Brain foods: the effects of nutrients on brain function , 2008, Nature Reviews Neuroscience.

[11]  P. Barberger‐Gateau,et al.  Plasma eicosapentaenoic acid is inversely associated with severity of depressive symptomatology in the elderly: data from the Bordeaux sample of the Three-City Study. , 2008, The American journal of clinical nutrition.

[12]  P. Zandi,et al.  Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: The Cache County Study , 2008, Alzheimer's & Dementia.

[13]  Victoria J. Bourne,et al.  n–3 Fatty acid erythrocyte membrane content, APOE ε4, and cognitive variation: an observational follow-up study in late adulthood , 2008 .

[14]  Alan J. Thomas,et al.  Depression and cognition in older adults , 2008, Current opinion in psychiatry.

[15]  M. V. van Boxtel,et al.  n 3 fatty acid proportions in plasma and cognitive performance in older adults. , 2007, The American journal of clinical nutrition.

[16]  K. Su,et al.  A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. , 2007, The Journal of clinical psychiatry.

[17]  A. Folsom,et al.  Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study. , 2007, The American journal of clinical nutrition.

[18]  E. Anil.  The impact of EPA and DHA on blood lipids and lipoprotein metabolism: influence of apoE genotype , 2007, Proceedings of the Nutrition Society.

[19]  M. Berger,et al.  Effects of fish oil on the neuro-endocrine responses to an endotoxin challenge in healthy volunteers. , 2007, Clinical nutrition.

[20]  J. Lake,et al.  Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. , 2006, The Journal of clinical psychiatry.

[21]  Henrik Zetterberg,et al.  Plasma Aβ in Alzheimer's disease—up or down? , 2006, The Lancet Neurology.

[22]  H. Soininen,et al.  Fat Intake at Midlife and Risk of Dementia and Alzheimer’s Disease: A Population-Based Study , 2006, Dementia and Geriatric Cognitive Disorders.

[23]  J. Guralnik,et al.  Association between serum beta-carotene levels and decline of cognitive function in high-functioning older persons with or without apolipoprotein E 4 alleles: MacArthur studies of successful aging. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[24]  David Loewenstein,et al.  Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. , 2006, Archives of general psychiatry.

[25]  Oscar L Lopez,et al.  Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. , 2006, Archives of general psychiatry.

[26]  V. Pankratz,et al.  Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study. , 2006, Archives of neurology.

[27]  Oscar L Lopez,et al.  Perspectives on depression, mild cognitive impairment, and cognitive decline. , 2006, Archives of general psychiatry.

[28]  J. Dartigues,et al.  APOE genotype, cholesterol level, lipid-lowering treatment, and dementia , 2005, Neurology.

[29]  Jean-François Dartigues,et al.  The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. , 2005, Brain : a journal of neurology.

[30]  J. Hibbeln,et al.  Omega-3 status and cerebrospinal fluid corticotrophin releasing hormone in perpetrators of domestic violence , 2004, Biological Psychiatry.

[31]  David E Newby,et al.  Omega 3 fatty acids and cardiovascular disease-- fishing for a natural treatment , 2003 .

[32]  G. Alexander,et al.  Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Holman,et al.  Vascular Factors and Risk of Dementia: Design of the Three-City Study and Baseline Characteristics of the Study Population , 2003, Neuroepidemiology.

[34]  B. Heude,et al.  Cognitive decline and fatty acid composition of erythrocyte membranes--The EVA Study. , 2003, The American journal of clinical nutrition.

[35]  R. Friedland,et al.  Interactions of apolipoprotein E genotype and dietary fat intake of healthy older persons during mid-adult life. , 2003, Metabolism: clinical and experimental.

[36]  D. Bennett,et al.  Depressive symptoms, cognitive decline, and risk of AD in older persons , 2002, Neurology.

[37]  R. Mayeux,et al.  Caloric intake and the risk of Alzheimer disease. , 2002, Archives of neurology.

[38]  Y. Stern.  What is cognitive reserve? Theory and research application of the reserve concept , 2002, Journal of the International Neuropsychological Society.

[39]  P R Houck,et al.  Decreased working memory and processing speed mediate cognitive impairment in geriatric depression , 2000, Psychological Medicine.

[40]  Anthony F Jorm,et al.  Is depression a risk factor for dementia or cognitive decline? , 2000, Neurobiology of Aging.

[41]  W. Jagust,et al.  The Role of APOE ∊4 in Modulating Effects of Other Risk Factors for Cognitive Decline in Elderly Persons , 1999 .

[42]  K Yaffe,et al.  Depressive symptoms and cognitive decline in nondemented elderly women: a prospective study. , 1999, Archives of general psychiatry.

[43]  D Commenges,et al.  A 5-year longitudinal study of the Mini-Mental State Examination in normal aging. , 1997, American journal of epidemiology.

[44]  C. Salles,et al.  One-step extraction of human erythrocyte lipids allowing rapid determination of fatty acid composition. , 1989, Analytical biochemistry.

[45]  K. Radack,et al.  Omega-3 Fatty Acids , 2021, Encyclopedia of Evolutionary Psychological Science.

[46]  D H Freeman,et al.  Depressive symptoms in relation to physical health and functioning in the elderly. , 1986, American journal of epidemiology.

[47]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[48]  L. Radloff.  The CES-D Scale , 1977 .

[49]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[50]  B Isaacs,et al.  The Set Test as an Aid to the Detection of Dementia in Old People , 1973, British Journal of Psychiatry.

[51]  R. Reitan.  The relation of the trail making test to organic brain damage. , 1955, Journal of consulting psychology.

[52]  J. Stockman,et al.  Longitudinal Modeling of Age-Related Memory Decline and the APOE ɛ4 Effect , 2011 .

[53]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[54]  Victoria J. Bourne,et al.  n-3 Fatty acid erythrocyte membrane content, APOE varepsilon4, and cognitive variation: an observational follow-up study in late adulthood. , 2008, The American journal of clinical nutrition.

[55]  M. Boxtel,et al.  Fatty acid proportions in plasma and cognitive performance in older adults 1 3 , 2007 .

[56]  George S Alexopoulos,et al.  Depression in the elderly , 2005, Lancet.

[57]  A. Madgulkar,et al.  Omega-3 fatty acids , 2005 .

[58]  M. Crawford,et al.  Is docosahexaenoic acid (DHA) essential? Lessons from DHA status regulation, our ancient diet, epidemiology and randomized controlled trials. , 2004, The Journal of nutrition.

[59]  J. Lindsay,et al.  Omega-3 fatty acids and risk of cognitive impairment and dementia. , 2003, Journal of Alzheimer's disease : JAD.

[60]  W. Jagust,et al.  The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. , 1999, JAMA.

[61]  A. Nissinen,et al.  Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. , 1998, Neuroepidemiology.

[62]  F. Rouillon,et al.  La version française de l'échelle CES-D (Center for Epidemiologic Studies-Depression Scale). Description et traduction de l'échelle d'autoévaluation. , 1989 .